According to a study published on 26 May 2026, in the European Journal of Cancer Care by Silan Yang’s & Zhihong Zhu’s team at the Affiliated Hospital of Jiaxing University, dyadic coping partially mediated the association between recurrence fears and depression. The cross-sectional analysis of 211 survivors shows that better mutual coping between couples significantly buffers depressive symptoms tied to disease progression anxiety.
Understanding the Psychological Toll of Gastrointestinal Cancer Survival
Better diagnostic methods and treatments have prolonged life expectancy for many individuals facing gastrointestinal cancer, bringing greater focus to their long-term mental well-being. According to the Chinese Academy of Sciences, fear that cancer may return or progress is common among survivors. This persistent anxiety links closely with clinical depression, reduced treatment adherence, and poorer quality of life.
Spouses often serve as primary caregivers, particularly for middle-aged and older patients. Daily communication and mutual emotional support heavily shape how couples respond to illness-related stress. Until recently, however, the precise psychological pathway connecting recurrence fears, shared coping mechanisms, and depression within the Chinese social and family context remained largely unclear. Researchers at the Affiliated Hospital of Jiaxing University set out to measure these exact dynamics.
Did you know?
According to findings published in the European Journal of Cancer Care, fear of cancer recurrence spans physical-health and social-family domains, directly impacting a survivor’s daily psychological well-being.
Methodology and Findings from the Jiaxing University Study
To investigate how couples handle these challenges, scientists carried out a cross-sectional survey utilizing questionnaires administered from February 2022 to June 2024 at a tertiary medical center located in Jiaxing, China. The study initially recruited 245 patients, 10 of whom declined to participate. From the total pool, questionnaires exhibiting significant missing information were excluded, leaving a final cohort of 211 participants who were married gastrointestinal cancer survivors aged 45 years or older who could independently understand and complete the survey. The average participant age was 62.45 years, and 63.98% were men.
Participants completed a demographic and clinical questionnaire alongside three validated instruments:
- The Fear of Progression Questionnaire-Short Form: Measured recurrence fears across physical-health and social-family domains.
- The Dyadic Coping Inventory: Measured stress communication, supportive coping, collaborative coping, negative coping, and related couple-level responses.
- The Hospital Anxiety and Depression Scale: Evaluated depressive symptoms using the depression subscale.
Statistical evaluations—including group comparisons, Pearson correlation analysis, and mediation analysis based on 10,000 bootstrap samples—controlled for living arrangement, occupation, residential area, and time since diagnosis. Average scores landed at 25.25 for fear of cancer recurrence, 129.56 for dyadic coping, and 18.47 for depression. Greater recurrence fear associated heavily with poorer dyadic coping (r = −0.390), while better dyadic coping tracked with lower depression scores (r = −0.408). Furthermore, recurrence fear showed a positive association with depression (r = 0.431), and all three correlations were statistically significant.
How Dyadic Coping Mediates Depression in Survivors
Mediation analysis revealed concrete numbers regarding how couple interactions influence mental health. According to the study data, recurrence fear had a direct effect of 0.083 on depression. Additionally, it exerted an inverse impact on dyadic coping, whereas dyadic coping itself demonstrated an inverse impact on depression levels.
The indirect effect through dyadic coping registered at 0.028, with a 95% confidence interval spanning from 0.015 to 0.045. This indirect pathway accounted for 25.23% of the total association. Because this was a single-center, cross-sectional study, researchers emphasize that the results demonstrate associations rather than causation and should be tested in multicenter longitudinal research.
Pro Tip for Clinicians:
Medical teams should assess how patients and spouses communicate, share stress, and provide mutual support. Integrating couple-based coping training and appropriate psychological interventions may help reduce depressive symptoms.
Future Directions for Couple-Based Psychological Interventions
The research highlights dyadic coping as a potentially adjustable protective element influencing the mental well-being of gastrointestinal cancer survivors in middle and older age brackets.
Investigators point out that extra studies are necessary to validate their utility across diverse populations and to track how these dynamics evolve over time. Parallel research published in nature.com regarding adolescent patients with malignant bone tumors and their caregivers underscores that medical staff should regard patients and caregivers as a whole, employing targeted psychological tools like mindfulness-based cognitive behavioral therapy when negative coping patterns emerge.
Frequently Asked Questions
What is dyadic coping?
The Dyadic Coping Inventory evaluates stress communication, supportive coping, collaborative coping, negative coping, and related couple-level responses.

How does fear of recurrence affect gastrointestinal cancer survivors?
Data from the Chinese Academy of Sciences indicates that anxiety regarding cancer recurrence or disease progression frequently impacts survivors, correlating strongly with depressive symptoms, decreased compliance with treatment plans, and diminished life quality.
Can couple-based interventions reduce depression?
The authors propose that joint coping workshops for couples along with targeted psychological support could decrease depressive symptoms, though broader investigations are required to verify their efficacy in varied groups and evaluate longitudinal shifts.
Join the Conversation
How has family support impacted your recovery journey or clinical practice? Share your thoughts in the comments below, or subscribe to our newsletter for the latest updates in oncology care.
Worth a look